Eric Jacobson

2.7k total citations
35 papers, 2.0k citations indexed

About

Eric Jacobson is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Eric Jacobson has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Geriatrics and Gerontology. Recurrent topics in Eric Jacobson's work include Sirtuins and Resveratrol in Medicine (9 papers), Click Chemistry and Applications (5 papers) and Cancer Treatment and Pharmacology (5 papers). Eric Jacobson is often cited by papers focused on Sirtuins and Resveratrol in Medicine (9 papers), Click Chemistry and Applications (5 papers) and Cancer Treatment and Pharmacology (5 papers). Eric Jacobson collaborates with scholars based in United States, United Kingdom and Netherlands. Eric Jacobson's co-authors include Ethan Hoffmann, Jonathan Haddad, D.P. Berry, Andreas J. Gescher, Karen Brown, Barbara C. Hegarty, George P. Vlasuk, W P Steward, Lynne Howells and Bernadette White and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The American Journal of Medicine.

In The Last Decade

Eric Jacobson

33 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Jacobson United States	21	619	532	387	324	319	35	2.0k
Paola Signorelli Italy	27	1.8k 2.9×	328 0.6×	615 1.6×	469 1.4×	368 1.2×	63	2.9k
Abishek Iyer Australia	28	998 1.6×	135 0.3×	427 1.1×	256 0.8×	445 1.4×	49	2.4k
Subhendu Mukherjee United States	23	701 1.1×	360 0.7×	106 0.3×	123 0.4×	275 0.9×	56	1.7k
Gayatri Ramakrishna India	24	786 1.3×	270 0.5×	167 0.4×	388 1.2×	751 2.4×	87	2.0k
Adam Csordás Austria	20	987 1.6×	221 0.4×	157 0.4×	187 0.6×	196 0.6×	47	1.7k
An Chen China	21	577 0.9×	154 0.3×	243 0.6×	152 0.5×	235 0.7×	74	1.5k
Ji Miao China	31	2.0k 3.3×	322 0.6×	274 0.7×	734 2.3×	979 3.1×	96	4.2k
Neus Carbó Spain	30	1.4k 2.2×	187 0.4×	399 1.0×	247 0.8×	401 1.3×	82	2.9k
Yifei Zhong China	23	932 1.5×	120 0.2×	274 0.7×	106 0.3×	221 0.7×	52	2.1k
Gagan Chhabra United States	20	641 1.0×	290 0.5×	130 0.3×	243 0.8×	182 0.6×	51	1.5k

Countries citing papers authored by Eric Jacobson

Since Specialization

Citations

This map shows the geographic impact of Eric Jacobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Jacobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Jacobson more than expected).

Fields of papers citing papers by Eric Jacobson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Jacobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Jacobson. The network helps show where Eric Jacobson may publish in the future.

Co-authorship network of co-authors of Eric Jacobson

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Jacobson. A scholar is included among the top collaborators of Eric Jacobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Jacobson. Eric Jacobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Differding, Jerome A., et al.. (2017). Evaluation of negative pressure wound therapy to closed laparotomy incisions in acute care surgery. The American Journal of Surgery. 215(1). 113–115. 31 indexed citations

Krueger, James G., Mayte Suárez‐Fariñas, Inna Cueto, et al.. (2015). A Randomized, Placebo-Controlled Study of SRT2104, a SIRT1 Activator, in Patients with Moderate to Severe Psoriasis. PLoS ONE. 10(11). e0142081–e0142081. 79 indexed citations

Sands, Bruce E., Jonathan Haddad, Johannes Freudenberg, et al.. (2015). Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis. Inflammatory Bowel Diseases. 22(3). 607–614. 37 indexed citations

Meer, Anne Jan van der, Brendon P. Scicluna, Perry D. Moerland, et al.. (2015). The Selective Sirtuin 1 Activator SRT2104 Reduces Endotoxin-Induced Cytokine Release and Coagulation Activation in Humans*. Critical Care Medicine. 43(6). e199–e202. 55 indexed citations

Elliott, Peter J., et al.. (2014). A phase II, randomized, placebo‐controlled, double‐blind, multi‐dose study of SRT2104, a SIRT1 activator, in subjects with type 2 diabetes. British Journal of Clinical Pharmacology. 78(1). 69–77. 66 indexed citations

Venkatasubramanian, Sowmya, Shruti Daga, Jeremy P. Langrish, et al.. (2013). Cardiovascular Effects of a Novel SIRT1 Activator, SRT2104, in Otherwise Healthy Cigarette Smokers. Journal of the American Heart Association. 2(3). e000042–e000042. 79 indexed citations

Wada, Yumiko, Irma Cardinale, Artemis Khatcherian, et al.. (2012). Apilimod Inhibits the Production of IL-12 and IL-23 and Reduces Dendritic Cell Infiltration in Psoriasis. PLoS ONE. 7(4). e35069–e35069. 55 indexed citations

Pinato, David J., et al.. (2012). Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers. PLoS ONE. 7(11). e49814–e49814. 10 indexed citations

Libri, Vincenzo, Giulio Gambarota, Jonathan Haddad, et al.. (2012). A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers. PLoS ONE. 7(12). e51395–e51395. 103 indexed citations

10.

Krausz, Sarah, Maria J H Boumans, Daniëlle M. Gerlag, et al.. (2011). Brief Report: A phase IIa, randomized, double‐blind, placebo‐controlled trial of apilimod mesylate, an interleukin‐12/interleukin‐23 inhibitor, in patients with rheumatoid arthritis. Arthritis & Rheumatism. 64(6). 1750–1755. 62 indexed citations

11.

Howells, Lynne, D.P. Berry, Eric Jacobson, et al.. (2011). Phase I Randomized, Double-Blind Pilot Study of Micronized Resveratrol (SRT501) in Patients with Hepatic Metastases—Safety, Pharmacokinetics, and Pharmacodynamics. Cancer Prevention Research. 4(9). 1419–1425. 346 indexed citations

12.

O’Day, Steven, René González, David H. Lawson, et al.. (2009). Phase II, Randomized, Controlled, Double-Blinded Trial of Weekly Elesclomol Plus Paclitaxel Versus Paclitaxel Alone for Stage IV Metastatic Melanoma. Journal of Clinical Oncology. 27(32). 5452–5458. 143 indexed citations

13.

Vergunst, Clarissa E., Daniëlle M. Gerlag, Lars Klareskog, et al.. (2008). Modulation of CCR2 in rheumatoid arthritis: A double‐blind, randomized, placebo‐controlled clinical trial. Arthritis & Rheumatism. 58(7). 1931–1939. 178 indexed citations

14.

Lawson, David H., René González, Robert Weber, et al.. (2008). 2-year overall survival (OS) results of a phase II trial of elesclomol (formerly STA-4783) and paclitaxel in stage IV metastatic melanoma (MM). Journal of Clinical Oncology. 26(15_suppl). 20023–20023. 6 indexed citations

15.

Burakoff, Robert, Charles F. Barish, Dennis Riff, et al.. (2006). A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohnʼs disease. Inflammatory Bowel Diseases. 12(7). 558–565. 82 indexed citations

16.

Stone, Sarah, Kathleen M. Mazor, Susan Starr, et al.. (2003). Development and Implementation of an Objective Structured Teaching Exercise (OSTE) to Evaluate Improvement in Feedback Skills Following a Faculty Development Workshop. Teaching and Learning in Medicine. 15(1). 7–13. 53 indexed citations

17.

Jacobson, Eric, Francis A. Ennis, Robert Edelman, et al.. (2001). Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. Vaccine. 19(28-29). 3957–3967. 107 indexed citations

18.

Jacobson, Eric, et al.. (1998). A Comparison of Inpatient and Outpatient Experiences during an Internal Medicine Clerkship. The American Journal of Medicine. 104(2). 159–162. 18 indexed citations

19.

Zurier, Robert B., Ronald G. Rossetti, Eric Jacobson, et al.. (1996). Gamma‐linolenic acid treatment of rheumatoid arthritis. A randomized, placebo‐controlled trial. Arthritis & Rheumatism. 39(11). 1808–1817. 141 indexed citations

20.

Jacobson, Eric, et al.. (1952). Anesthetic management in cardiac catheterization and angiocardiography.. PubMed. 52(15). 1866–70.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact